Astria Therapeutics Stock (NASDAQ:ATXS), Quotes and News Summary

Q: What sector and industry does Astria Therapeutics (ATXS) operate in?

Astria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Astria Therapeutics Stock (NASDAQ: ATXS) stock price, news, charts, stock research, profile.

Open	$9.500
Close	-
Volume / Avg.	356.097K / 1.036M
Day Range	9.360 - 9.860
52 Wk Range	4.260 - 16.900
Market Cap	$523.459M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	9.58%
Days to Cover	2.8

Recent News

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.

Avi Kapoor

$5.6M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Avi Kapoor

Exxon Mobil To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Astria Therapeutics (ATXS) stock?

You can purchase shares of Astria Therapeutics (NASDAQ: ATXS) through any online brokerage.

View our list of the best stock brokerages.

Who are Astria Therapeutics's (ATXS) competitors?

Other companies in Astria Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Voyager Therapeutics (NASDAQ:VYGR).

What is the target price for Astria Therapeutics (ATXS) stock?

The latest price target for Astria Therapeutics (NASDAQ: ATXS) was reported by HC Wainwright & Co. on Tuesday, April 23, 2024. The analyst firm set a price target for 16.00 expecting ATXS to rise to within 12 months (a possible 67.85% upside). 16 analyst firms have reported ratings in the last year.

Current Stock Price for Astria Therapeutics (ATXS)?

The stock price for Astria Therapeutics (NASDAQ: ATXS) is $9.5325 last updated Today at May 3, 2024 at 3:47 PM EDT.

Does Astria Therapeutics (ATXS) pay a dividend?

There are no upcoming dividends for Astria Therapeutics.

When is Astria Therapeutics (NASDAQ:ATXS) reporting earnings?

Astria Therapeutics’s Q1 earnings are confirmed for Friday, May 17, 2024.

Is Astria Therapeutics (ATXS) going to split?

There is no upcoming split for Astria Therapeutics.

What sector and industry does Astria Therapeutics (ATXS) operate in?

Astria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-